Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Expert Review of Anticancer Therapy|March 11, 2010
Unresolved issues in diffuse large B-cell lymphomasNiels Murawski, Carsten Zwick, Michael PfreundschuhSeminars in Hematology|March 31, 2010
Rituximab in high-grade lymphomaCarsten Zwick, Niels Murawski, Michael Pfreundschuh, et al.Clinical Lymphoma & Myeloma|March 8, 2008
Aspects of chemotherapy schedules in young and elderly patients with aggressive lymphomaCarsten Zwick, Beate Gleissner, Michael PfreundschuhImmunological Reviews|November 26, 2002
Analysis of the B-cell repertoire against antigens expressed by human neoplasmsKlaus-Dieter Preuss, Carsten Zwick, Claudia Bormann, et al.International Journal of Cancer|February 14, 2015
CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemiaFrank Neumann, Michael Pfreundschuh, Klaus D Preuss, et al.Blood|April 13, 2013
Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cellsCarsten Zwick, Natalie Fadle, Evi Regitz, et al.Annals of Hematology|February 25, 2009
Analysis of the antibody repertoire of patients with mantle cell lymphoma directed against mantle cell lymphoma-associated antigensCarsten Zwick, Klaus-Dieter Preuss, Boris Kubuschok, et al.Cancer Immunology, Immunotherapy : CII|April 27, 2013
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumorsFrank Neumann, Dominic Kaddu-Mulindwa, Thomas Widmann, et al.Journal of Cancer Research and Clinical Oncology|February 24, 2009
Spontaneous high-titered IgG antibody responses against BCL-2 in patients with aggressive lymphomasCarsten Zwick, Gerhard Held, Vera Hammermeister, et al.Human Gene Therapy|September 13, 2012
Mutated Ras-transfected, EBV-transformed lymphoblastoid cell lines as a model tumor vaccine for boosting T-cell responses against pancreatic cancer: a pilot trialBoris Kubuschok, Michael Pfreundschuh, Rainer Breit, et al.Pageof 3